Aurobindo Pharma has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Montelukast Sodium Tablets 10mg (ANDA 202468) and Montelukast Sodium Chewable Tablets 4mg and 5mg (ANDA202096). The products are ready for a first-day launch.
Montelukast Sodium Tablets 10mg and Chewable Tablets 4mg and 5mg are the generic equivalent of Merck & Co. Inc
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
